Hercules Capital (HTGC), a venture debt-focused business development company, has seen its share price premium to net asset value (NAV) decrease from 72% to 30% in 2024. Despite this compression, the company continues to pay a strong dividend yield of 12.1%, supported by a base dividend of $0.40 and a supplemental quarterly dividend of $0.07. The base dividend is well covered, with first-quarter net investment income covering 120% of it. Additionally, the portfolio's credit quality remains strong, with nonaccruals at just 0.1% of the total investment portfolio as of the end of the first quarter. This suggests that while market sentiment around technology-focused BDCs has softened, Hercules Capital maintains solid financial health and income generation for investors.
Willis Towers Watson, a global advisory firm, is poised for growth with a 25.3% potential stock upside, driven by new initiatives like KwantSure, a digital insurance sales channel for subcontractors, and a Geospatial Mortality Model to improve pensio...
AngioDynamics reported an 8% revenue increase to $86.6 million in Q4, driven by a 16.7% sales rise in its Med Tech division, notably from NanoKnife and AlphaVac products. H.C. Wainwright raised the price target from $16 to $19 and maintained a Buy ra...
PNC Financial Services Group reported Q2 2026 adjusted EPS of $4.85 and record revenue of $6.88 billion, surpassing analyst expectations. The growth was driven by a 15.5% rise in net interest income and a 31.4% increase in fee income, reflecting stro...
Greenlight, a leading cannabis operator, expanded its Ohio presence by opening four new dispensaries and adding in-state manufacturing, reaching the state's maximum allowed eight dispensaries. This move strengthens Greenlight's position in Ohio's lim...
Halper Sadeh LLC is investigating whether shareholders of Element Solutions Inc (ESI), Crinetics Pharmaceuticals (CRNX), and Solstice Advanced Materials (SOLS) are receiving fair treatment in their respective sale and merger transactions. The firm hi...
